The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo. [electronic resource]
Producer: 20110505Description: 2673-82 p. digitalISSN:- 1878-5905
- Administration, Oral
- Animals
- Blood Glucose -- drug effects
- Drug Delivery Systems -- methods
- Electric Impedance
- Epithelial Cells -- drug effects
- Exenatide
- Freeze Drying
- Hydrogen-Ion Concentration -- drug effects
- Injections, Subcutaneous
- Insulin -- metabolism
- Insulin Secretion
- Male
- Molecular Dynamics Simulation
- Nanoparticles -- chemistry
- Particle Size
- Peptides -- administration & dosage
- Pharmaceutical Vehicles -- chemistry
- Rats
- Rats, Wistar
- Solubility -- drug effects
- Static Electricity
- Tablets, Enteric-Coated -- pharmacology
- Time Factors
- Tissue Distribution -- drug effects
- Tomography, Emission-Computed, Single-Photon
- Tomography, X-Ray Computed
- Venoms -- administration & dosage
- Whole Body Imaging
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.